Zwittermicin A is a novel aminopolyol antibiotic that represents a new structural class of antibiotic and has diverse biological activities, including the suppression of plant disease and the ability to inhibit prokaryotic and eukaryotic cells. To enhance our fundamental understanding and applications of zwittermicin A, we elucidated mechanisms of zwittermicin A resistance in Escherichia coli. Two classes of zwittermicin Aresistant mutants of E. coli were selected and characterized. One class included mutants altered in hemA, hemB, hemL, ubi, cydAB or atp, which were defective in generating a proton motive force (PMF) and resistant to aminoglycosides. The mutant analysis, coupled with physiological data, indicated an association between the electrical membrane potential (⌬⌿) component of PMF and zwittermicin A sensitivity. A second class of zwittermicin A-resistant mutants was aminoglycoside sensitive and was affected in rpoB and rpoC, genes that encode subunits of RNA polymerase. The rpoB and rpoC mutants suggested that zwittermicin A might inhibit transcription, DNA replication, DNA gyrase or topoisomerase I; however, we found no further evidence to support any of these as the target for zwittermicin A. This study elucidated the genetic mechanisms of zwittermicin A resistance in E. coli. The results suggest that ⌬⌿ drives zwittermicin A uptake, and that, unlike other antibiotics for which resistance maps in rpoB or rpoC, zwittermicin A does not cause the rapid cessation of DNA or RNA synthesis, suggesting a unique mechanism of antibiosis.
Introduction
Zwittermicin A is a novel, broad-spectrum antibiotic produced by Bacillus cereus Silo-Suh, 1994; Stabb et al., 1994; Milner et al., 1995) . Zwittermicin A inhibits the growth of eukaryotic and prokaryotic microorganisms and is particularly active against enteric bacteria, such as Escherichia coli, and plant pathogenic oomycetes belonging to the genera Phytophthora, Pythium and Aphanomyces (Silo-Suh, 1994) . Zwittermicin A also contributes to the ability of B. cereus to suppress certain plant diseases . Zwittermicin A producers are ubiquitous in soil (Stabb et al., 1994) , suggesting that it may be an ecologically important antibiotic. The unique structure of zwittermicin A (He et al., 1994, Fig. 1) may reflect a novel mechanism of inhibition in target organisms, which could make zwittermicin A a valuable new tool in cell biology. Based on its broad target range and inhibition of plant pathogens, zwittermicin A may also be useful in agriculture or medicine. The utility of zwittermicin A will be enhanced by an understanding of resistance mechanisms in target organisms.
Current knowledge of zwittermicin A, including its structure and activity spectrum, does not suggest the mechanism of resistance. The diversity of microorganisms inhibited by zwittermicin A may indicate an evolutionarily conserved target and uptake systems, but does not implicate any particular one. As a small, linear aminopolyol, zwittermicin A constitutes a new class of antibiotic and, therefore, resistance mechanisms cannot be predicted from the structure. Zwittermicin A shares certain structural features with other antibiotics, but these reflect diverse structures and modes of action, including amine-containing ionophores, minor groove-binding basic oligopeptides, the polycationic transcription inhibitor, chitosan, the arginine analogue, canavanine, and aminoglycoside antibiotics, which inhibit translation and interfere with membrane integrity (Hadwinger et al., 1986; Leuba and Stossel, 1986; Van Bambeke et al., 1993; Lancini et al., 1995) . Thus, it is difficult to predict, based on the spectrum of activity and structure, the cellular target for zwittermicin A, the mechanism by which it reaches its target or the basis for zwittermicin A resistance.
The goal of this study was to determine genetic mechanisms of resistance to zwittermicin A. We present the characterization of two classes of zwittermicin A-resistant mutants of E. coli. One class is affected in genes whose products are involved in maintaining a membrane potential, and the other is affected in genes encoding subunits of RNA polymerase.
Results
The goal of this study was to investigate mechanisms of zwittermicin A resistance in prokaryotes. Our approach was to select and characterize zwittermicin A-resistant mutants of E. coli. Mutants of strain MG1655 resistant to zwittermicin A arose spontaneously at a frequency of 2 × 10 ¹8 and formed small colonies. Twelve independent mutations were mapped by determining the co-transduction frequency of zwittermicin A resistance loci and Tn10 markers of known location on the E. coli chromosome (Singer et al., 1989) . The mutations conferring zwittermicin A resistance mapped to six loci, at 4, 9, 17, 27, 83 and 87 map units on the E. coli chromosome (Table 1) .
Mutants affected in haem biosynthesis
Zwittermicin A resistance in mutant MGZ10 mapped to the region at 4 map units on the E. coli chromosome (Table 1) . We isolated plasmids that restored a large colony phenotype and zwittermicin A sensitivity to strain MGZ10 Mu c ts, and Southern blot analysis indicated that these plasmids contained inserts from the 4 map unit region (data not shown). The region overlapped by three of these clones included hemL ( Fig. 2A) , which encodes glutamate 1-semialdehyde aminotransferase, an enzyme in the haem biosynthetic pathway (Ilag et al., 1991) . Similarly, the mutations in MGZ01 and MGZ09 mapped near hemA at 27 map units, and the mutation in MGZ11 mapped near hemB at 9 map units (Table 1) . hemA and hemB also encode enzymes in the haem biosynthetic pathway, glutamyl-tRNA reductase and ␦-aminolaevulinic acid (ALA) dehydratase respectively. Plasmids carrying hemA (Chen et al., 1994) or hemB restored zwittermicin A sensitivity and wild-type colony morphology on the putative hemA or hemB mutants respectively; control plasmids that contained incomplete or interrupted hemA or hemB or no insert did not restore these phenotypes ( Fig. 2B and C) . The enzymes encoded by hemL and hemA contribute to the synthesis of the haem precursor ALA, so, to test whether ALA deficiency caused zwittermicin A resistance in MGZ10, MGZ01 and MGZ09, we added ALA to the growth medium, and this restored zwittermicin A sensitivity and wild-type colony morphology to these mutants. These data indicate that zwittermicin A resistance is conferred by mutations in hemL, hemA or hemB that result in a deficiency in haem biosynthesis.
Mutants affected in the cytochrome d terminal oxidase
The mutation conferring zwittermicin A resistance on strain ᮊ 1998 Blackwell Science Ltd, Molecular Microbiology, 27, 311-322 Singer et al. (1989) , updated by Berlyn et al. (1996) . b. (Green and Gennis, 1983; Green et al., 1984) . To test whether a deficiency in cyd production results in zwittermicin A resistance, we assayed cyd ¹ mutant GR84N (Green et al., 1984) and found that it was resistant to zwittermicin A. Furthermore, zwittermicin A sensitivity and wild-type colony morphology were restored to MGZ06 by plasmid pNG2, a derivative of pBR322 that carries the cydAB operon (Green et al., 1984) , whereas pBR322 did not affect these phenotypes. These data indicate that the elimination of cyd confers zwittermicin A resistance and that the zwittermicin A resistance of MGZ06 is caused by a lesion in cyd.
Mutants affected in ubiquinone biosynthesis
The mutations conferring zwittermicin A resistance on mutants MGZ05, MGZ07 and MGZ12 were mapped to the region at 87 map units on the E. coli chromosome (Table 1) . Based on co-transduction frequencies with other nearby markers (data not shown), the mutation in MGZ05 was localized counterclockwise from fadAB, in the vicinity of ubiB and ubiD (Cox et al., 1969; Daniels et al., 1992) , which encode enzymes involved in the biosynthesis of ᮊ 1998 Blackwell Science Ltd, Molecular Microbiology, 27, 311-322 Fig. 2 . A. Placement of pES102, pES103 and pESMGB inserts relative to the E. coli chromosome. The solid black line (top) represents the region of the E. coli chromosome from 3.25-3.75 map units. The portions of the chromosome contained on the inserts of pES103, pES102 and pESMGB are shown as boxes aligned under the corresponding region of the chromosome. The shaded portions of the boxes represent regions aligned by sequence identity to the corresponding chromosomal region; the remaining, unshaded portions are inferred based on insert size. The region overlapped by all three plasmids is expanded, and open reading frames identified in the sequence of this region (Fujita et al., 1994) the electron carrier, ubiquinone (Young et al., 1973) . Consistent with a disruption of ubiquinone biosynthesis, mutants MGZ05, MGZ07 and MGZ12 did not grow under ubiquinone-dependent conditions, aerobically with malate or succinate as a carbon source, but grew well under conditions that do not require ubiquinone, aerobically or anaerobically on glucose or anaerobically on glycerol and nitrate (Cox et al., 1968; Lin and Kuritzkes, 1987; Wissenbach et al., 1990) . Furthermore, we found that a previously described ubiD mutant, AN66 (Cox et al., 1969) , was resistant to zwittermicin A, while its parent strain, AN2154, was sensitive to zwittermicin A, demonstrating that deficiency in ubiquinone production confers zwittermicin A resistance.
Mutants in membrane-bound energy-generating ATPase
The mutations conferring zwittermicin A resistance on mutants MGZ02, MGZ03, MGZ04 and MGZ08 mapped near the atp locus at 83 map units on the E. coli chromosome (Table 1) . MGZ02, MGZ03, MGZ04 and MGZ08 grew with glucose but not with succinate or malate as the carbon source, which is a phenotype typical of atp mutants (Adler and Rosen, 1976) , and pAP55, which carries the atp operon (Brusilow et al., 1983) , restored zwittermicin A sensitivity and wild-type colony morphology to these mutants, while the vector alone did not affect these phenotypes.
Some previously described atp mutants are 'leaky', deregulating the flow of protons through the membrane, and are decreased in the uptake of various solutes (Rosen, 1973; Damper and Epstein, 1981; Humbert and Altendorf, 1989) . One such 'leaky' mutant, TK1207 (Damper and Epstein, 1981) , was resistant to zwittermicin A, and its parent strain, FRAG5, was sensitive to zwittermicin A. The proton 'leak' in mutants such as TK1207 can be blocked with DCCD (Rosen, 1973; Damper and Epstein, 1981) , and DCCD dramatically increased the zwittermicin A sensitivity of strains MGZ02, MGZ03, MGZ04 and MGZ08, but had little effect on the zwittermicin A sensitivity of the wild-type strain MG1655 or the hemB mutant MGZ11 (Table 2 ). These data indicate that strains MGZ02, MGZ03, MGZ04 and MGZ08 are atp mutants and are zwittermicin A resistant, because they deregulate the flow of protons through the cytoplasmic membrane.
Association between zwittermicin A resistance and membrane potential Mutants, such as those described above, with 'leaky' membrane-bound ATPases or alterations in electron transport functions, such as haem, cytochrome or ubiquinone biosynthesis, are reduced in proton motive force (PMF) and its electrical membrane potential (⌬⌿) component. We tested the zwittermicin A sensitivity of wild-type E. coli strain MG1655 under conditions that decrease ⌬⌿, including increased osmolarity, lowered external pH and the addition of the uncoupler 2,4-dinitrophenol (Damper and Epstein, 1981) , and found that all of these conditions increased the minimal inhibitory concentration (MIC) of zwittermicin A 1.7-to 20-fold (Fig. 3) . Decreases in external pH decrease ⌬⌿ but increase PMF and its ⌬pH component (Harold and Maloney, 1996) , so the decreases in zwittermicin A sensitivity, in both the mutants and the culture conditions, are consistently associated with decreases in ⌬⌿, not in PMF. Furthermore, decreased ⌬⌿ is correlated with decreased uptake of and low-level resistance to aminoglycoside antibiotics (Damper and Epstein, 1981) , and all 12 Zm r mutants were resistant to low levels of the aminoglycosides, streptomycin, gentamicin and kanamycin, while remaining sensitive to non-aminoglycosides, such as tetracycline, chloramphenicol and ampicillin. To test the relationship between zwittermicin A sensitivity and ⌬⌿ quantitatively, we measured sensitivity to aminoglycosides as an indirect assessment of ⌬⌿. This approach was based on the finding (Damper and Epstein, 1981) that the logarithm of the minimal inhibitory concentrations [log(MIC)] of dihydrostreptomycin and of kanamycin are linearly and inversely related to the magnitude of ⌬⌿. We found that the log(MIC) of zwittermicin A was directly correlated with the log(MIC) of dihydrostreptomycin (r 2 ¼ 0.91) (Fig. 3 ) and with the log(MIC) of kanamycin among 12 culture conditions or mutants (r 2 ¼ 0.84) (data not shown). Taken together, the data indicate an inverse relationship between ⌬⌿ and zwittermicin A resistance.
Isolation of zwittermicin A-resistant, aminoglycosidesensitive mutants
Mutations that lower ⌬⌿ decrease aminoglycoside uptake and confer low-level, non-specific aminoglycoside resistance, whereas selection of high-level resistance to specific ᮊ 1998 Blackwell Science Ltd, Molecular Microbiology, 27, 311-322 aminoglycosides results in alterations in their ribosomal target (Thorbjarnardó ttir et al., 1978; Davis, 1987) . Similarly, mutations that affected ⌬⌿ also affected zwittermicin A sensitivity, possibly by affecting uptake; thus, to obtain mutants altered in the intracellular target for zwittermicin A, we selected high-level zwittermicin A resistance and screened for mutants that were aminoglycoside sensitive. Spontaneous mutants resistant to 300 g ml ¹1 zwittermicin A were not observed among 10 10 cells plated. However, after ethylmethane sulphonate (EMS) mutagenesis, mutants resistant to this level of zwittermicin A were obtained. Fifty-six zwittermicin A-resistant mutants derived from an EMS-mutagenized culture were screened for sensitivity to streptomycin, gentamicin and kanamycin, and four mutants, each of which produced small colonies, were aminoglycoside sensitive. The colony morphology of MGZ201, MGZ202 and MGZ203 was stable in the absence of zwittermicin A, facilitating their characterization. These three mutants were sensitive to chloramphenicol and tetracycline, indicating that they were not multiple antibioticresistant mutants of the sort mapped to the mar locus (George and Levy, 1983a,b) . However, MGZ201 was resistant to nalidixic acid, which inhibits DNA gyrase, and MGZ202 was resistant to rifampicin, which inhibits RNA polymerase. The mutants obtained in this selection were easily distinguishable from the mutants affected in ⌬⌿, as the mutants described here were resistant to equal or higher levels of zwittermicin A but were as sensitive as the wild type to aminoglycosides (as measured by zone sizes in radial streak tests).
Mutations in rpoB and rpoC
The mutations conferring zwittermicin A resistance on MGZ201, MGZ202 and MGZ203 mapped to the region containing rpoB and rpoC, which encode the two largest subunits of RNA polymerase, at 90 map units on the E. coli chromosome (Table 1) . To test whether the growth deficiency of these mutants was caused by alterations in rpoB or rpoC, we transformed the mutants with plasmids bearing wild-type copies of these genes. MGZ201 and MGZ203 formed larger colonies when transformed with pRW308, which carries wild-type rpoC (Weilbaecher et al., 1994) , than when transformed with the control vector, pTrc99c. Neither pRW308 nor pRL385, which carries rpoB (Landick et al., 1990) , restored wild-type colony morphology to MGZ202. Induction of expression of a plasmid-borne rpoC under control of the trp/lac promoter increased the zwittermicin A sensitivity of MGZ201 and MGZ203 (Table  3) , demonstrating a correlation between rpoC and zwittermicin A resistance/sensitivity in these mutants. Marker exchange analysis of MGZ201, MGZ202 and MGZ203, using plasmids bearing portions of rpoB or rpoC, identified particular regions of these genes necessary for small colony morphology and zwittermicin A resistance in the mutants (Fig. 4) . Subsequent sequencing of these regions revealed, in each case, a GC to AT transition typical of EMS mutagenesis (Miller, 1992) , resulting in the alteration of an evolutionarily conserved amino acid residue in RNA polymerase; RpoB E1329K in MGZ202, and RpoC G916D and S1324L in MGZ201 and MGZ203 respectively (Fig. 5) . Induction of expression of the rpoC S1324L allele, carried on plasmid p3502 (Weilbaecher et al., 1994) , conferred increased zwittermicin A resistance on the wild type (Table 3 ). These data indicate that mutations affecting RNA polymerase confer resistance to zwittermicin A.
Zwittermicin A does not inhibit DNA or RNA synthesis
Mutations in the genes encoding subunits of RNA polymerase have been shown to confer resistance to antibiotics that inhibit transcription, such as rifampicin (Jin and Gross, 1988) , and those that inhibit DNA gyrase and therefore DNA replication, such as novobiocin and nalidixic acid (Blanc-Potard et al., 1995) . We tested the possibility that zwittermicin A inhibits transcription or DNA replication. (Fig. 6) . In similar experiments, the growth rate (as measured by the OD 600 ) of zwittermicin A-treated cultures slowed within 15 min of zwittermicin A addition, showing that the antibiotic was active in this time frame. These results indicate that zwittermicin A does not inhibit total RNA or DNA synthesis.
Nalidixic acid causes DNA gyrase to form doublestranded breaks in DNA, inducing SOS-response genes, such as dinD. Unlike nalidixic acid, zwittermicin A did not induce a dinD::lacZ fusion in E. coli. Novobiocin causes the progressive unwinding of negatively supercoiled DNA and thereby induces certain superhelicity-sensitive promoters, such as that in the his operon (Blanc-Potard et al., 1995) . In contrast to novobiocin, zwittermicin A did not induce transcription of the hisD::lacZ fusion in Salmonella typhimurium.
The effects of zwittermicin A and novobiocin on bacterial growth were antagonistic (Stabb, 1997) . Mutations in topA, which affect topoisomerase I activity, are also antagonistic to novobiocin (Hammond et al., 1991) , so we tested whether zwittermicin A acts on topoisomerase I. Zwittermicin A did not inhibit the unwinding of plasmid DNA by topoisomerase I in vitro (data not shown). Thus, despite the fact that mutations in RNA polymerase confer zwittermicin A resistance, we found no evidence that zwittermicin A affects cellular functions previously associated with RNA polymerase, including RNA synthesis, DNA synthesis or DNA gyrase or topoisomerase I activity.
ᮊ 1998 Blackwell Science Ltd, Molecular Microbiology, 27, 311-322 a. Plasmids pRW308 and p3502 contain the wild-type rpoC and mutant rpoC3502 (S1324L) expressed and regulated by the trp /lac promoter and lacI q -encoded repressor, respectively, in vector pTrc99c (Amann et al., 1988) . b. MIC was determined by measuring the minimum concentration of zwittermicin A required to prevent visible growth after inoculating 10 5 cells of E. coli strain MG1655 in 1 ml of medium and shaking in a 28ЊC incubator for 24 h. Fig. 4 . Marker exchange mapping. Large colony, zwittermicin A-sensitive recombinants of strains MGZ201, MGZ202 and MGZ203 appeared when these Zm r mutants were transformed with plasmids carrying certain portions of rpoB and rpoC. The top line represents the E. coli chromosome, and thick portions represent the coding regions of (from left) the 3Ј end of rpoB and rpoC respectively. Plasmids are listed in the leftmost column, and the insert in each plasmid is shown as a thin line to the right of the plasmid name beneath the corresponding region of the E. coli chromosome. The three columns at the right indicate the stability of mutant transformants; þ, indicates instability marked by the appearance of large-colony, zwittermicin A-sensitive recombinants; ¹, indicates the transformant stably maintained mutant colony morphology and zwittermicin A resistance. nd, not determined. The shaded boxes at the bottom indicate the regions amplified and sequenced in mutants MGZ202, MGZ201 and MGZ203 (from left to right).
Discussion
Two distinct classes of E. coli mutants were resistant to zwittermicin A: one class was defective in the ability to generate PMF and was resistant to both zwittermicin A and aminoglycosides, and the second class was zwittermicin A resistant, aminoglycoside sensitive and affected in RNA polymerase. The mutants altered in PMF suggested an association between ⌬⌿ and zwittermicin A sensitivity, and this was supported by other genetic and physiological lines of evidence. We propose that ⌬⌿ contributes to zwittermicin A uptake. The mutants with altered RNA polymerase suggested that zwittermicin A might inhibit transcription, DNA replication, gyrase or topoisomerase activity. However, we found no evidence to indicate that any of these is the target for zwittermicin A. The mutants and the observation that zwittermicin A and novobiocin have antagonistic activities will contribute to the elucidation of the mode of action of zwittermicin A.
Association between ⌬⌿ and zwittermicin A sensitivity
Zwittermicin A resistance is probably associated with decreases in ⌬⌿ not decreases in PMF or ⌬pH. Zwittermicin A resistance mapped to genes whose products contribute to the respiratory generation of PMF, and its ⌬⌿ and ⌬pH components, but it is unlikely that zwittermicin A resistance is associated with ⌬pH, as ⌬⌿ is the major contributor to PMF during respiratory growth at pH 8.1, the pH at which we selected for zwittermicin A resistance (Harold and Maloney, 1996) . Furthermore, lowering external pH, which increases PMF and ⌬pH and decreases ⌬⌿ (Damper and Epstein, 1981; Harold and Maloney, 1996) , increased zwittermicin A resistance (Fig. 3) , indicating that zwittermicin A resistance is consistently associated with decreased ⌬⌿ rather than with decreased PMF or ⌬pH. Also consistent with the hypothesis that ⌬⌿ is associated with zwittermicin A sensitivity is the observation ᮊ 1998 Blackwell Science Ltd, Molecular Microbiology, 27, 311-322 Shaded regions cover amino acids that are identical to the E. coli sequence, and gaps are shown to achieve better alignment. X marks the locations of mutant alleles; RpoB E1329 (A), RpoC G916 (B) and RpoC and S1324 (C.). ), which inhibits DNA synthesis, and rifampicin (300 g ml ¹1 ), which inhibits RNA synthesis, are included as controls. A total of 500 g ml ¹1 zwittermicin A was added. Time of antibiotic addition is indicated by an arrow.
that, over a range of mutants and culture conditions, the level of zwittermicin A sensitivity was directly correlated with the level of aminoglycoside sensitivity (Fig. 3) , and a correlation between aminoglycoside sensitivity and ⌬⌿ has been demonstrated previously (Damper and Epstein, 1981) . While ⌬⌿ has been suggested as being involved in the sensitivity of bacteria to a number of antibiotics, direct evidence is lacking in most cases. Moreover, not all positively charged antibiotics require ⌬⌿ for activity. Thus, it is significant that we have extended this mechanism of sensitivity to a new class of antibiotic.
Given the large number of genes devoted to the generation of PMF and ⌬⌿, it may seem surprising that we found a relatively low frequency of spontaneous zwittermicin A resistance (2 × 10 ¹8 ); however, our selection demanded mutants deficient in ⌬⌿ but still able to grow on medium not amended with a fermentable sugar. Thus, we may have selected against relatively common lossof-function mutants in respiratory processes. Direct evidence to support this argument is that the mutant hemL allele in MGZ10 increases both the growth and the zwittermicin A sensitivity of this mutant when carried on a multicopy plasmid, indicating that this mutation does not confer a complete loss of function. Furthermore, the distribution of loci conferring zwittermicin A resistance and, in particular, the relatively high proportion of ubi and atp mutants is similar to the distribution of aminoglycoside-resistant mutants obtained in similar studies (Sasarman et al., 1968; Kanner and Gutnick, 1972; Rosen, 1973; Adler and Rosen, 1976; Bryan and Van Den Elzen, 1977; Thorbjarnardó ttir et al., 1978; Humbert and Altendorf, 1989; Ilag et al., 1991; O'Neill et al., 1991) .
The ⌬⌿ normally maintained by E. coli consists of a relative negative charge inside the cell, which can drive the uptake of positively charged compounds electrogenically. Decreasing ⌬⌿ enhances resistance to the positively charged aminoglycoside antibiotics by decreasing their electrogenically driven uptake, although the exact mechanism of uptake and the role of aminoglycoside structure and mode of action during uptake is unresolved (Damper and Epstein, 1981; Davis, 1987; Taber et al., 1987) . It seems likely that a decrease in ⌬⌿ reduces sensitivity to zwittermicin A, which is positively charged, by reducing its net uptake. However, the recent report that sensitivity to protamine, an antibiotic that inhibits cytoplasmic membrane functions, is related to ⌬⌿ (Aspedon and Groisman, 1996) underscores the need to test this hypothesis directly. Whether zwittermicin A uptake is related to ⌬⌿ will be tested directly when radiolabelled zwittermicin A is available. Biosynthesis or organic synthesis of labelled zwittermicin A requires either more efficient production and purification methods or more information than is currently available about the biosynthetic pathway or the stereochemistry of zwittermicin A.
RNA polymerase mutants may provide insight into the mode of action of zwittermicin A If ⌬⌿ drives zwittermicin A uptake as it does aminoglycoside uptake, then the three aminoglycoside-sensitive zwittermicin A-resistant mutants described here presumably confer resistance through alteration of the intracellular target for zwittermicin A, not by affecting uptake. Transduction and molecular characterization of these three mutants revealed an association between zwittermicin A resistance and mutations in rpoB or rpoC, genes encoding RNA polymerase subunits. Previously isolated mutations affecting RNA polymerase confer resistance to transcriptional inhibitors and/or gyrase inhibitors. In fact, our mutants, MGZ201 and MGZ202, were resistant to the transcription inhibitor rifampicin and the gyrase inhibitor nalidixic acid respectively. However, we found no evidence to show that transcription or gyrase is affected by zwittermicin A. Interestingly, novobiocin, which causes the relaxation of chromosomal DNA, reduced the activity of zwittermicin A (Stabb, 1997) . Novobiocin acted additively, not antagonistically, with the aminoglycoside kanamycin (data not shown), indicating that its effects on zwittermicin A sensitivity are probably not mediated by effects on ⌬⌿. Based on the lack of direct inhibition in vitro or in vivo of transcription, gyrase or topoisomerase I, zwittermicin A appears to behave differently from most antibiotics for which resistance has mapped to RNA polymerase.
The intriguing conflict between the zwittermicin A resistance of RNA polymerase mutants and our inability to detect an effect of zwittermicin A on DNA or RNA synthesis may suggest a more subtle mode of action not detected by our assays. For example, zwittermicin A might inhibit transcription in a promoter-specific fashion preventing expression of a small number of essential genes, or zwittermicin A might inhibit transcription termination in a sitespecific manner. Promoter-specific transcriptional effects would not be unprecedented; the antibiotics gramicidin, netropsin and distamycin appear to inhibit or promote transcription in a context-dependent manner (Keilman et al., 1975; Sarkar et al., 1977; 1979; Bruzik et al., 1987) . It is also possible that the mode of action of zwittermicin A is unrelated to transcription and that RNA polymerase mutants confer resistance to zwittermicin A by altering the expression of a particular gene or genes whose product(s) directly confer(s) zwittermicin A resistance. Mutations in rpoB have long been known to affect gene expression and confer resistance to tryptophan analogue antibiotics by altering transcription pausing and termination in the trp operon (Yanofsky and Horn, 1981; Fisher and Yanofsky, 1983) . Four experimental approaches that will help to distinguish among these and other models are: (i) examination of gene expression in wild-type cells treated with zwittermicin A; (ii) comparison of gene expression between wild-type and zwittermicin A-resistant rpoB and rpoC mutants; (iii) characterization of the properties (elongation and termination rates, etc.) of mutant RNA polymerases that confer zwittermicin A resistance; and (iv) sequencing a large number of resistance-conferring rpoB and rpoC alleles. The rpoC S1324L allele, which conferred zwittermicin A resistance, was previously isolated in a selection for mutant rpoC alleles that conferred altered transcriptional termination properties (Weilbaecher et al., 1994) . Examination of the other defined rpoC alleles conferring altered termination properties will determine whether zwittermicin A resistance and termination phenotypes are consistently associated with or coincidental to the S1324L allele. The outcomes of these experiments, combined with the wealth of basic understanding of E. coli RNA polymerase, should provide insight into the mode of action of zwittermicin A.
Experimental procedures
Bacteria, phage, plasmids and media Lambda phages were amplified in E. coli LE392 (Murray et al., 1977) . Luria broth (LB; Miller, 1992) and 56 minimal base medium (Monod et al., 1951) were prepared as described except that NaCl was added to LB at a concentration of 5.0 g l ¹1 . MHMT8.1 was prepared by amending Mueller Hinton medium (Difco Laboratories) with 40 mM MOPS and 40 mM Tris and adjusting the pH to 8.1 with NaOH. MHMT7.1 and MHMT6.1 were adjusted to pH 7.1 or 6.1, respectively, with HCl. When added to media, ALA, kanamycin, tetracycline, chloramphenicol and ampicillin were used at concentrations of 50, 40, 10, 30 and 75 g ml were obtained from NEN Life Science Products. Zwittermicin A was purified by cation exchange chromatography on an Amberlite IRL-50 resin (Sigma) followed by high-performance liquid chromatography (HPLC) with a cyano-bonded phase column, according to a protocol to be described elsewhere.
DNA manipulations and analysis T4 ligase and restriction enzymes were obtained from Promega, except Bcl I, HpaI and Pst I (New England Biolabs). Plasmids and lambda phage DNA were purified with Wizard Minipreps or Wizard Lambda Preps respectively (Promega). Between restriction and ligation reactions, and before transformation, DNA was recovered with the Qiaex gel extraction kit (Qiagen). The sizes of DNA inserts in pES102, pES103 and pESMGB were estimated by EcoRV digestion and gel electrophoresis. Southern blot analysis, electroporation-mediated transformation and DNA sequencing were performed as described previously (Milner et al., 1996) . For Southern blot analysis, probes were generated from 117, 119 and 120 (Fujita et al., 1994) . Primer 5Ј-CCAATGTCCCGGTTTTT-3Ј directed sequencing of inserts in plasmids pES102, pES103 and pESMGB. To sequence regions of rpoB or rpoC, template DNA was obtained from boiled lysates of cultures by polymerase chain reaction (PCR) amplification with Pfu polymerase (Stratagene), followed by gel purification of the product. In each case, the products of at least two separate amplifications were sequenced, producing identical results. The primers for amplification and sequencing of MGZ201 DNA were 5Ј-CAT-GAAGCTTGTTCTGTTGTATCTTGTGACACCG-3Ј and 5Ј-C-ATGGGATCCCAG-TTTCAGTTCAGTATTACGGG-3Ј. The primers used to analyse MGZ202 were 5Ј-CGGTTTTAGT-CTGCGCTTTCAG-3Ј, 5Ј-CTGATGGTTGCCGTCCACGAT-G-3Ј, 5Ј-TGGAGCCGGGCATGCCAGA-ATC-3Ј and 5Ј-AGC-CTGGTTACTCAGCAGCCGC-3Ј. The primers for the analysis of MGZ203 DNA were 5Ј-CGTTAACGCGGGTAGCTCCGA-C-3Ј, 5Ј-CTCCCCCCATAAAAAAACCCG-CCGA-3Ј, 5Ј-TC-TCCTGGAACGATGCCGCGGAGAT-3Ј, 5Ј-CGTGGTGAC-GTAATTTCCGACGGT-3Ј and 5Ј-ACCAAAGCGTCTCTGG-CAACCGAGT-3Ј. Primer synthesis and sequencing were done at the University of Wisconsin Biotechnology Center. Sequencing was conducted on an ABI Model 373A automated DNA sequencer, and comparison of DNA sequences was conducted using the BLASTN algorithm (Altschul et al., 1990) .
Plasmid construction
Plasmids pES102, pES103 and pESMGB were generated by the in vivo cloning method described by Groisman and Casadaban (1986) . pES102 and pES103 contain inserts derived from MGZ10 Mu cts, and the insert in pESMGB was derived from MG1655 Mu cts. We determined that these transformants were increased in sensitivity to zwittermicin A by both radial streak tests and determination of MICs. The inserts in these plasmids were identified by determining the insert sizes, sequencing one end of each insert and aligning the sequences with the E. coli chromosome (Fujita et al., 1994) . Plasmids pHBS and pHBHE were deletion derivatives of plasmid pBKS-::hemN#13, which contains the same 3.1 kb BamH1 fragment carrying hemB as pUC18ALABam3 (O'Neill et al., 1991) inserted in pBluescriptKS-, and were generated by digesting pBKS-::hemN#13 with Sal I, and HpaI and EcoRV, respectively, and self-ligating the resulting fragments. Plasmids pHBHEKP and pHBHEKB contain the Kan r cassette from pUC4K (Vieira and Messing, 1982) inserted in pHBHE at the Pst I and BamHI sites respectively. Plasmids pEVS10, pEVS11 and pEVS12 were generated by digesting pMSB29 with Bcl I and BamHI, EcoRI and PvuII, respectively, and selfligating the resulting fragments to create deletion derivatives of pMSB29. Plasmids, with the exception of pES102, pES103 and pESMGB, were maintained in strain DH5␣ (Hanahan, 1983) .
Assays of antibiotic sensitivity
Antibiotic sensitivity was tested qualitatively in radial streak tests (Milner et al., 1996) on MHMT8.1 plates with antibiotics added to filter disks in the following amounts: zwittermicin A (150 g), tetracycline (5 g), chloramphenicol (10 g), ampicillin (15 g), gentamicin (2 g), kanamycin (5 g), streptomycin (5 g), nalidixic acid (25 g) or rifampicin (75 g). Sensitivity to zwittermicin A, dihydrostreptomycin or kanamycin was tested semiquantitatively by a minimal inhibitory concentration (MIC) test. Approximately 10 5 cells were added to 1 ml of broth (MHMT8.1 unless otherwise stated) containing the appropriate antibiotic. The cultures were shaken at 28ЊC for 24 h, and the lowest concentration of antibiotic at ᮊ 1998 Blackwell Science Ltd, Molecular Microbiology, 27, 311-322 which no growth was visible was considered the MIC. The reported MICs reflect typical results of at least three independent determinations.
Selection of zwittermicin A-resistant mutants
We selected mutants in MHMT8.1 at 28ЊC because MG1655 appeared to be most sensitive to zwittermicin A under these conditions. A single colony of MG1655 was used to inoculate MHMT8.1 broth (in 17 separate experiments). The culture was shaken for 8-12 h in a 28ЊC incubator and then spread on solid medium containing 150 g ml ¹1 zwittermicin A, and the plates were incubated for 48 h. Selection of zwittermicin A-resistant mutants after mutagenesis was performed as described above, except that 300 g ml ¹1 zwittermicin A was used. Mutagenesis with EMS was performed as described previously (Miller, 1992) , resulting in a 40% reduction in cfus after EMS exposure.
Assays of antibiotic activities
To test the ability of antibiotics to induce E. coli dinD1::Mu d1(Ap r lac) or S. typhimurium hisD::Mu d1(Ap r lac) fusions, strains PN104 (Nurse et al., 1991) and TT7692, respectively, were spread on LB plates containing 40 g ml ¹1 Xgal. Antibiotic-containing filter disks were placed on the plates, which were incubated at 37ЊC for 24 h. A zone of blue, darker than the lawn, surrounding a zone of inhibition was scored as induction. Inhibition of transcription by E. coli RNA polymerase holoenzyme was tested in vitro as described previously (Weilbaecher et al., 1994) , with or without the addition of zwittermicin A (300 g ml
¹1
). Briefly, a linear DNA fragment carrying the bacteriophage T7A1 promoter and the Rho-independent T7 early terminator served as the template, and transcription products containing [ 32 P]-GTP were visualized on gels. Zwittermicin A was preincubated with either the DNA template or the RNA polymerase enzyme with similar results. Inhibition of topoisomerase I activity was assayed in vitro as described previously (Burton and Kaguni, 1997) , using cell-free lysate from an E. coli topA overexpresser as a source of topoisomerase I and supercoiled pUC18 DNA as a substrate, with or without zwittermicin A (300 g ml
). Topoisomerase I-containing lysate was generously provided by Neil Bowlby, Michigan State University. To measure the effect of antibiotics on the incorporation of methyl-[
